Apple Health Outcome

Peptides for rem sleep

No compounds in the catalog are flagged to track rem sleep yet.

REM sleep and dreaming-stage architecture

REM sleep is the dreaming stage, concentrated in the second half of the night, and is associated with memory consolidation and emotional processing. Adults spend roughly 20–25% of sleep time in REM. Alcohol, late caffeine, and many antidepressants reduce REM; THC reduces REM significantly.

Peptides do not specifically target REM sleep. GH secretagogues primarily increase deep (slow-wave) sleep, with a smaller and inconsistent effect on REM. Users sometimes report more vivid dreams when starting CJC-1295/ipamorelin, which is consistent with an architectural shift but not a duration-targeted effect.

If REM is the primary deficit you’re seeing in Apple Watch data, the first interventions are typically not peptide-class: alcohol reduction, fixed sleep timing, and (with a prescriber) reviewing any medications that suppress REM.

Compounds in Regimen tracked for rem sleep

0 compounds

No compounds match .

Try a different search term or clear the outcome filter.

Frequently asked questions

Can I increase REM sleep with peptides?

There is no peptide with robust evidence for REM-specific enhancement. GH secretagogues primarily affect deep sleep. If your goal is more REM, the highest-yield interventions are behavioral and pharmacological (alcohol/THC reduction, reviewing SSRIs and similar REM-suppressors with your prescriber) rather than peptide-based.

Why does Regimen track REM separately?

Total sleep duration alone can mask architectural shifts. A user whose total sleep is unchanged but whose REM rises from 60 to 90 minutes is sleeping better, even if the scale on the watch face looks identical. Tracking each stage separately makes the structural change visible alongside your dose log.

Related reading

Best peptide tracker app in 2026

An honest multi-protocol comparison of Regimen, PeptIQ, Shotsy, MeAgain, and the GLP-1 calculator apps.

Other outcomes